[APLS] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
05-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 1.78%
YoY- -94.11%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 22,056 5,650 646 0 0 0 0 -
PBT -190,823 -195,571 -135,700 -69,825 -35,972 -11,573 -7,211 72.58%
Tax 446 2,165 9,483 540 -281 -11,589 -7,234 -
NP -191,269 -195,571 -135,700 -69,825 -35,972 -11,573 -7,211 72.64%
Tax Rate - - - - - - - -
Total Cost 213,325 201,221 136,346 69,825 35,972 11,573 7,211 75.81%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -867.20 -3,461.43 -21,006.19 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -1.75 -2.28 -1.79 -1.10 -0.64 -0.30 -0.40 27.87%
EPS Diluted -1.75 -2.28 -1.79 -1.10 -0.64 -0.30 -0.40 27.87%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.